Biotech stocks continue to dominate charts I am watching. The stock flagged in the second half of December, broke out, and then flagged again in late January before its latest upmove. On Tuesday it popped $1.39, or 8%, to $18.85 on big volume of 1.9 million shares. The stock followed through on Monday and then again yesterday, up $2.48, or 14%, to $20.14 on nearly 3.4 million shares. Exelixis, Inc. (EXEL) also had a strong session on Tuesday, up another 54 cents, or 2.7%, to $20.57, on nearly 6.7 million shares traded.

Source: Forbes February 08, 2017 18:49 UTC